Group XIV C-type lectins: emerging targets in tumor angiogenesis is a research paper published in Angiogenesis (2024). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: T32 Cancer Immunotherapy and Experimental Therapeutics
National Institutes of Health
Grant: R01CA269644
NCI NIH HHS
Grant: R01 CA279398
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: R01 CA258302
National Institutes of Health
Grant: 5R01CA269644-03
Melanoma Immunotherapy with GPR182 blockade
National Institutes of Health
Grant: 1R01CA279398-01
The GPR171 pathway in cancer immunotherapy
National Institutes of Health
Grant: 5R01CA258302-04
The CD93 pathway and melanoma therapy
Wings of Hope for Pancreatic Cancer Research
FWCI
2.24
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals